BEL FUSE INC /NJ (BELFB) Dividend Safety
- Dividend payout ratio · 12 months: Value 5.27%; Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | 5.27% | Cash dividends paid / net income. Period ending 2026-06-30. $3.49M ÷ $66.23M × 100 ≈ 5.27% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | 3.49M USD | Payments of Dividends |
| Net income · 12 months | 66.23M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | $3.49M | $66.23M | 5.27% |
| 2026-03-31 | $3.48M | $67.62M | 5.14% |
| 2025-12-31 | $3.46M | $61.54M | 5.63% |
| 2025-09-30 | $3.46M | (m) | (m) |
| 2025-06-30 | $3.44M | (m) | (m) |
| 2025-03-31 | $3.44M | $42.96M | 8.02% |
| 2024-12-31 | $3.45M | $40.96M | 8.43% |
| 2024-09-30 | $3.49M | $54.80M | 6.37% |
| 2024-06-30 | $3.51M | $66.16M | 5.30% |
| 2024-03-31 | $3.50M | $75.13M | 4.66% |
| 2023-12-31 | $3.49M | $73.83M | 4.73% |
| 2023-09-30 | $3.43M | $75.83M | 4.53% |
| 2023-06-30 | $3.42M | $72.93M | 4.70% |
| 2023-03-31 | $3.42M | $62.20M | 5.50% |
| 2022-12-31 | $3.41M | $52.69M | 6.48% |
| 2022-09-30 | $3.40M | $46.66M | 7.29% |
| 2022-06-30 | $3.40M | $35.84M | 9.47% |
| 2022-03-31 | $3.39M | $26.69M | 12.69% |
| 2021-12-31 | $3.38M | $24.82M | 13.61% |
| 2021-09-30 | $3.39M | $20.36M | 16.64% |
| 2021-06-30 | $3.38M | $22.11M | 15.29% |
| 2021-03-31 | $3.37M | $19.80M | 17.03% |
| 2020-12-31 | $3.36M | $12.79M | 26.28% |
| 2020-09-30 | $3.37M | $2.89M | 116.56% |
| 2020-06-30 | $3.37M | $-11.07M | -30.39% |
| 2020-03-31 | $3.36M | $-13.68M | -24.55% |
| 2019-12-31 | $3.35M | $-8.74M | -38.34% |
| 2019-09-30 | $3.32M | $1.63M | 203.30% |
| 2019-06-30 | $3.31M | $19.48M | 16.98% |
| 2019-03-31 | $3.30M | $23.14M | 14.28% |
| 2018-12-31 | $3.29M | $20.71M | 15.91% |
| 2018-09-30 | $3.31M | $-4.10M | -80.67% |
| 2018-06-30 | $3.31M | $-10.43M | -31.71% |
| 2018-03-31 | $3.29M | $-13.95M | -23.60% |
| 2017-12-31 | $3.28M | $-11.90M | -27.58% |
| 2017-09-30 | $3.28M | $12.27M | 26.72% |
| 2017-06-30 | $3.27M | $16.95M | 19.27% |
| 2017-03-31 | $3.26M | $36.61M | 8.89% |
| 2016-12-31 | $3.25M | $-64.83M | -5.01% |
| 2016-09-30 | $3.26M | $-65.32M | -4.99% |
| 2016-06-30 | $3.25M | $-70.11M | -4.64% |
| 2016-03-31 | $3.24M | $-86.82M | -3.74% |
| 2015-12-31 | $3.24M | $19.20M | 16.87% |
| 2015-09-30 | $3.19M | $18.57M | 17.15% |
| 2015-06-30 | $3.18M | $14.91M | 21.30% |
| 2015-03-31 | $3.17M | $12.16M | 26.06% |
| 2014-12-31 | $3.16M | $9.10M | 34.74% |
| 2014-09-30 | $3.12M | $14.47M | 21.54% |
| 2014-06-30 | $3.11M | $20.34M | 15.29% |
| 2014-03-31 | $3.10M | $18.97M | 16.36% |
| 2013-12-31 | $3.11M | $15.91M | 19.56% |
| 2013-09-30 | $3.14M | $7.29M | 43.08% |
| 2013-06-30 | $3.17M | $1.97M | 160.77% |
| 2013-03-31 | $3.21M | $973.00K | 329.39% |
| 2012-12-31 | $3.23M | $2.40M | 134.26% |
| 2012-09-30 | (m) | $5.02M | (m) |
| 2012-06-30 | (m) | $3.43M | (m) |
| 2012-03-31 | $3.21M | $1.40M | 229.87% |
| 2011-12-31 | $3.21M | $3.76M | 85.15% |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | $3.18M | $13.65M | 23.31% |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | $3.14M | $-8.31M | -37.75% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.